Thermo Fisher Scientific has raised $2.2 billion through a three-part sale of senior unsecured notes. The first tranche of $300 million notes, which carry a coupon rate of 2.05%, will mature in 2014, while the second tranche of $900 million notes, which carry a coupon rate of 3.2%, will mature in 2016.
The third tranche of $1 billion notes, which carry a coupon rate of 4.5%, will mature in 2021. The company may use the sale proceeds of the offering to fund its acquisition of Dionex as well as for general corporate purposes. The analytical instruments, laboratory equipment, software services provider appointed Barclays and JP Morgan as the joint book-running managers on the deal.
Click here for the story release Business Wire.